Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

EIR SCIENCES ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   2.6% 2.6% 2.6% 2.6% 2.6% 2.6% 2.6% 2.6%   Bankruptcy risk   17.3% 8.6% 5.1% 4.5% 6.1% 6.1% 14.6% 14.6%   Credit score (0-100)   10 30 43 45 38 37 15 15   Credit rating   BB BB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   279 0 0 0 0 0 0 0   Gross profit   89.7 569 966 2,124 1,951 3,763 0.0 0.0   EBITDA   2.6 155 140 315 141 157 0.0 0.0   EBIT   2.6 155 140 315 141 157 0.0 0.0   Pre-tax profit (PTP)   2.6 148.0 130.7 306.7 127.5 135.5 0.0 0.0   Net earnings   2.0 93.2 100.6 240.3 99.4 122.4 0.0 0.0   Pre-tax profit without non-rec. items   2.6 148 131 307 127 136 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   82.0 175 221 361 306 428 348 348   Interest-bearing liabilities   6.6 6.1 6.4 6.4 6.4 6.8 0.0 0.0   Balance sheet total (assets)   157 436 1,244 1,032 1,437 1,949 348 348   Net Debt   -148 -141 -914 -780 -419 -329 -348 -348     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   279 0 0 0 0 0 0 0   Net sales growth   -65.7% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   89.7 569 966 2,124 1,951 3,763 0.0 0.0   Gross profit growth   -78.6% 534.2% 69.7% 119.9% -8.2% 92.9% -100.0% 0.0%   Employees   1 5 1 1 1 1 0 0   Employee growth %   0.0% 400.0% -80.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   157 436 1,244 1,032 1,437 1,949 348 348   Balance sheet change%   -56.7% 178.1% 185.5% -17.1% 39.3% 35.6% -82.1% 0.0%   Added value   2.6 154.8 139.9 314.9 141.3 157.1 0.0 0.0   Added value %   0.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   -1.0 -2.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   2.9% 27.2% 14.5% 14.8% 7.2% 4.2% 0.0% 0.0%   Net Earnings %   0.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   1.0% 52.3% 16.9% 27.7% 11.4% 9.4% 0.0% 0.0%   ROI %   3.0% 114.7% 69.4% 105.9% 41.6% 42.8% 0.0% 0.0%   ROE %   2.5% 72.5% 50.8% 82.6% 29.8% 33.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   52.3% 40.2% 17.8% 35.0% 21.3% 22.0% 100.0% 100.0%   Relative indebtedness %   26.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   -28.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -5,763.2% -90.8% -653.2% -247.7% -296.8% -209.3% 0.0% 0.0%   Gearing %   8.1% 3.5% 2.9% 1.8% 2.1% 1.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 107.3% 176.8% 128.3% 216.6% 367.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.1 1.7 1.2 1.5 1.3 1.3 0.0 0.0   Current Ratio   2.1 1.7 1.2 1.5 1.3 1.3 0.0 0.0   Cash and cash equivalent   154.7 146.8 920.4 786.2 425.8 335.8 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   56.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   82.0 175.2 220.9 361.1 305.6 427.9 0.0 0.0   Net working capital %   29.4% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   279 0 0 0 0 0 0 0   Added value / employee   3 31 140 315 141 157 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   3 31 140 315 141 157 0 0   EBIT / employee   3 31 140 315 141 157 0 0   Net earnings / employee   2 19 101 240 99 122 0 0